Oncology Clinical Development Medical Director

GSK; Mississauga; Hybrid; CAD 180.000 - 280.000; Vollzeit

Zusammenfassung

GSK is seeking a Medical Director in Oncology Clinical Development with a focus on Lung & Head/Neck cancers. The role includes medical monitoring, data interpretation, and collaboration with cross‑functional teams to ensure safety and scientific integrity across studies.

Based in a hybrid environment, the position requires leadership in protocol development, regulatory submissions, and external scientific engagement while aligning with the CDL and broader programme strategy.

Qualifikationen

• MD (or equivalent) with oncology board certification or eligibility.
• Strong experience in oncology clinical trials and drug development.
• Proven ability to lead cross-functional clinical teams and communicate findings.

Aufgaben

• Serve as the physician within the clinical programme team, providing medical expertise across study design, conduct, safety oversight, and data interpretation.
• Lead medical monitoring activities for clinical studies, ensuring patient safety, clinical integrity, and compliance with the protocol and regulatory requirements.
• Interpret clinical and safety data from a physician perspective, generating insights that inform study‑level and programme‑level decisions led by the CDL.
• Partner with the Senior Scientist to ensure medical considerations are integrated into study execution, data generation, and operational delivery.
• Contribute to regulatory documents, Health Authority interactions, and scientific communications from a physician perspective.

Kenntnisse

Oncology clinical development

Medical monitoring

Regulatory strategy

Cross-functional leadership

Ausbildung

MD (Oncology)

Jobbeschreibung

GSK is seeking a Medical Director in Oncology Clinical Development with a focus on Lung & Head/Neck cancers. The role includes medical monitoring, data interpretation, and collaboration with cross‑functional teams to ensure safety and scientific integrity across studies.

Based in a hybrid environment, the position requires leadership in protocol development, regulatory submissions, and external scientific engagement while aligning with the CDL and broader programme strategy.